Ticker
IRWDCompany Name
IRONWOOD PHARMACEUTICALS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ 29.98M | 9.72% | $ 308.52M |
3/31/2025 | $ 78.52M | 24.72% | $ 317.68M |
12/31/2024 | $ 103.55M | 29.47% | $ 351.41M |
9/30/2024 | $ 124.17M | 32.81% | $ 378.42M |
6/30/2024 | $ 146.74M | 36.63% | $ 400.56M |
3/31/2024 | $ 148.24M | 35.85% | $ 413.55M |
12/31/2023 | $ 183.43M | 41.43% | $ 442.74M |
9/30/2023 | $ 226.78M | 52.45% | $ 432.38M |
6/30/2023 | $ 263.41M | 61.65% | $ 427.28M |
3/31/2023 | $ 289.81M | 69.48% | $ 417.13M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / Revenues
(=) OCF %
OCF % for IRONWOOD PHARMACEUTICALS INC is calculated as follows: CF - Operations [ $ 144.9M ] / Revenues [ $ 399.14M ]
(=) OCF % [ 36.3% ]
Minimum
Jun 30, 2025
Maximum
Mar 31, 2023
Average
Median
filtered constituents | 3.25K |
---|---|
min | -57.27% |
max | 77.08% |
average | 14.31% |
median | 12.65% |
std | 21.13% |